From the Griffin report
"While information was still limited, it appears that the deal will require multiple production lines to meet the demand for Unifill syringes and that some may be located in or near the customer’s drug manufacturing plants."
Will these new lines be situated overseas - France maybe?
Cant see any point in a new production facility in America.
Any thoughts anyone?
- Forums
- ASX - By Stock
- UNS
- 4 new research reports
4 new research reports, page-2
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)